Moleculin Biotech, Inc. MBRX

It’s real simple, assuming 1:8 r/s, power held by the outstanding shares would be 29% of authorized in aggregate currently and after, would be down to 3.6%. Why?…because they keep the authorized shares at 100,000,000 in the proposal. There’s your hidden devil in the detail behind the proxy.

Set the damn meeting for August 11-15 re the rs, not June 15. You got 6 mos + before nasdaq worries. Next qrt report/update better be talking about pivotal trial dates with fda on board or we’ll be having a totally different discussion then.

All you need to do is look at the aftermath of CNSP close cousin company November split of 1:30 and see how rapidly it plunged to under $1 and now just $1-2 range. Get off their butts and increase the sites to gain trial participants and get this damn thing into pivotal trial. Success not smoke and mirrors drive stock price

So what was the meeting outcome?

11:30 Eastern

More retail stock purchases by insiders would be helpful.

Exactly correct

I’ll take the hit on sp if needed but I’ve decided to abstain on all the proxy vote selections. It’s absurd to grant additional power to the CEO and board on progress I can’t confirm. Too many mixed signals and a vote like this is premature without more confidence. The May 25 annual meeting should be postponed at least 3 months and only after truncating p2 and going pivotal with an FDA meeting. Recruiting desperate candidates should be an easy sell if you believe the current facts and if it’s not, something is wrong with communication or facts. Give me a pivotal trial kickoff and I’ll give you full consideration to some/all of management’s power grab proposals. I would think the quarterly report would be a very reasonable target date.

Black Rock

Drip Drip Boom